Innovatus Pledges $42M to PGDx to Support IVD Development

Oct 04, 2018

|

NEW YORK (GenomeWeb) – Investment firm Innovatus Capital Partners said today that it has entered into a financing agreement with Personal Genome Diagnostics, providing up to $42 million in capital to support the company's efforts to advance in vitro diagnostics for genomic testing in cancer patients.

The investment firm didn't disclose further terms.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Innovatus Pledges $42M to PGDx to Support IVD Development

To read the full story....

Breaking News

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

NIH Funds $33M in COVID-19 Testing Projects for Safe Return of Students, Staff to School

Cancer Dx Firm C2i Genomics Raises $100M in Financing

Centogene Q4 Revenues Grow Almost Fivefold, Driven by COVID-19 Testing

Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

Snibe Diagnostic Obtains CE Mark for HIV Chemiluminescence Immunoassay

What's Popular?

Thermo Fisher Scientific to Acquire Contract Research Organization PPD for $17.4B

FDA Grants EUAs for SARS-CoV-2 Tests From Clinical Enterprise, Qorvo Biotechnologies

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

Antelope Dx Collaborates With In The Pocket, Extra Horizon to Develop Self-Tests

Sponsorships